Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Occlusive versus non-occlusive CPAP interfaces in neonatal respiratory care: a comparative review of efficacy and safety.

Created on 24 Sep 2026

Authors

Aleksandra Hibner, Samantha Hietalati, Sandra Lawrynowicz Leibel

Published in

European respiratory review : an official journal of the European Respiratory Society. Volume 35. Issue 181. Epub Sep 23, 2026.

Abstract

Continuous positive airway pressure (CPAP) is first-line therapy for respiratory distress in preterm infants, but optimal interface selection remains controversial. Occlusive interfaces (nasal prongs and masks with tight seals) provide accurate pressure delivery but can cause significant nasal trauma, while non-occlusive interfaces (loosely fitting nasal cannulae) reduce trauma but may compromise therapeutic efficacy.
To synthesise current evidence comparing occlusive with non-occlusive CPAP interfaces regarding pressure delivery accuracy, clinical efficacy, safety outcomes and practical implementation in neonatal intensive care.
Comprehensive review of randomised controlled trials, systematic reviews, bench studies and observational studies comparing CPAP interface types in preterm neonates. Evidence quality assessed using the Grading of Recommendations Assessment, Development and Evaluation criteria where applicable.
Occlusive interfaces deliver pressure within 0.5-1.0 cmH2O of set values and demonstrate superior efficacy in landmark trials (COIN, SUPPORT), particularly in extremely preterm infants (<28 weeks' gestation). However, nasal trauma rates reach 20-60%. Non-occlusive systems reduce trauma dramatically (0-5.4% injury rates) but consistently underdeliver pressure. Non-occlusive systems have failed to meet non-inferiority criteria in recent trials, with CPAP failure rates of 19.7% versus 17.3% for occlusive systems. This increased to failure rates >50% in extremely preterm infants.
Current evidence supports occlusive CPAP as first-line therapy for moderate-to-severe respiratory distress in preterm neonates, particularly those of <32 weeks' gestation. Non-occlusive interfaces may be appropriate for stable infants, weaning support or apnoea of prematurity management. Adequately powered randomised trials stratified by gestational age and respiratory severity are urgently needed to define optimal interface selection strategies.

PMID:
42778200
Bibliographic data and abstract were imported from PubMed on 24 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 28
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement